Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Autor: Hu, Yue-Mei, Bi, Zhao-Feng, Zheng, Ya, Zhang, Li, Zheng, Feng-Zhu, Chu, Kai, Li, Ya-Fei, Chen, Qi, Quan, Jia-Li, Hu, Xiao-Wen, Huang, Xing-Cheng, Zhu, Kong-Xin, Wang-Jiang, Ya-Hui, Jiang, Han-Min, Zang, Xia, Liu, Dong-Lin, Yang, Chang-Lin, Pan, Hong-Xing, Zhang, Qiu-Fen, Su, Ying-Ying, Huang, Shou-Jie, Sun, Guang, Huang, Wei-Jin, Huang, Yue, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Zdroj: In Science Bulletin 30 October 2023 68(20):2448-2455
Databáze: ScienceDirect